Editas Medicine, Inc.
CRISPR/Cas-related methods and compositions for treating herpes simplex virus

Abstract:

CRISPR/CAS-related systems, compositions and methods for editing RS1, RL2, and/or LAT genes in human cells are described, as are cells and compositions including cells edited according to the same.